To Order: patrick@cotinis.com
CD22 Polyclonal Antibody |
|||
ES8813-100ul | ELK Biotech | 100ul | EUR 334.8 |
Description: A Rabbit Polyclonal antibody against CD22 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
CD22 Polyclonal Antibody |
|||
ES8813-50ul | ELK Biotech | 50ul | EUR 248.4 |
Description: A Rabbit Polyclonal antibody against CD22 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
CD22 Polyclonal Antibody |
|||
ES8024-100ul | ELK Biotech | 100ul | EUR 334.8 |
Description: A Rabbit Polyclonal antibody against CD22 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
CD22 Polyclonal Antibody |
|||
ES8024-50ul | ELK Biotech | 50ul | EUR 248.4 |
Description: A Rabbit Polyclonal antibody against CD22 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
CD22 Rabbit pAb |
|||
A5790-100ul | Abclonal | 100 ul | EUR 369.6 |
CD22 Rabbit pAb |
|||
A5790-200ul | Abclonal | 200 ul | EUR 550.8 |
CD22 Rabbit pAb |
|||
A5790-20ul | Abclonal | 20 ul | EUR 219.6 |
CD22 Rabbit pAb |
|||
A5790-50ul | Abclonal | 50 ul | EUR 267.6 |
CD22 (phospho Tyr807) Polyclonal Antibody |
|||
ABP57024-003ml | Abbkine | 0.03ml | EUR 189.6 |
Description: A polyclonal antibody for detection of CD22 phospho Tyr807) from Human. This CD22 phospho Tyr807) antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human CD22 around the phosphorylation site of Y807 |
CD22 (phospho Tyr807) Polyclonal Antibody |
|||
ABP57024-01ml | Abbkine | 0.1ml | EUR 346.8 |
Description: A polyclonal antibody for detection of CD22 phospho Tyr807) from Human. This CD22 phospho Tyr807) antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human CD22 around the phosphorylation site of Y807 |
CD22 (phospho Tyr807) Polyclonal Antibody |
|||
ABP57024-02ml | Abbkine | 0.2ml | EUR 496.8 |
Description: A polyclonal antibody for detection of CD22 phospho Tyr807) from Human. This CD22 phospho Tyr807) antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human CD22 around the phosphorylation site of Y807 |
CD22 (phospho Tyr807) Polyclonal Antibody |
|||
ES8023-100ul | ELK Biotech | 100ul | EUR 334.8 |
Description: A Rabbit Polyclonal antibody against CD22 (phospho Tyr807) from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
CD22 (phospho Tyr807) Polyclonal Antibody |
|||
ES8023-50ul | ELK Biotech | 50ul | EUR 248.4 |
Description: A Rabbit Polyclonal antibody against CD22 (phospho Tyr807) from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
Anti CD22 Antibody: CD22 Monoclonal Antibody |
|||
065-A-01mg | Virogen | 0,1 mg | EUR 321 |
Description: anti-CD22 monoclonal antibody |
Anti CD22 Antibody: CD22 Monoclonal Antibody |
|||
065-A-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: anti-CD22 monoclonal antibody |
CD22 antibody |
|||
10-2485 | Fitzgerald | 250 ug | EUR 590.4 |
Description: Mouse monoclonal CD22 antibody |
CD22 antibody |
|||
10-2486 | Fitzgerald | 250 ug | EUR 590.4 |
Description: Mouse monoclonal CD22 antibody |
CD22 antibody |
|||
10-2487 | Fitzgerald | 250 ug | EUR 590.4 |
Description: Mouse monoclonal CD22 antibody |
CD22 antibody |
|||
70R-13701 | Fitzgerald | 100 ug | EUR 386.4 |
Description: Affinity purified Rabbit polyclonal CD22 antibody |
CD22 antibody |
|||
20R-2730 | Fitzgerald | 50 ug | EUR 337.2 |
Description: Rabbit polyclonal CD22 antibody |
CD22 Antibody |
|||
33045-100ul | SAB | 100ul | EUR 302.4 |
CD22 antibody |
|||
10R-CD22cMS | Fitzgerald | 500 ug | EUR 548.4 |
Description: Rat monoclonal CD22 antibody |
CD22 antibody |
|||
20R-1528 | Fitzgerald | 100 ug | EUR 807.6 |
Description: Rabbit polyclonal CD22 antibody |
CD22 Antibody |
|||
21492-100ul | SAB | 100ul | EUR 302.4 |
CD22 Antibody |
|||
21492-50ul | SAB | 50ul | EUR 224.4 |
CD22 Antibody |
|||
ABD7646 | Lifescience Market | 100 ug | EUR 525.6 |
CD22 Antibody |
|||
ABD7647 | Lifescience Market | 100 ug | EUR 525.6 |
CD22 Antibody |
|||
ABD7648 | Lifescience Market | 100 ug | EUR 525.6 |
CD22 Antibody |
|||
ABD7651 | Lifescience Market | 100 ug | EUR 525.6 |
CD22 Antibody |
|||
ABD7665 | Lifescience Market | 100 ug | EUR 525.6 |
CD22 antibody |
|||
70R-CR021 | Fitzgerald | 50 ug | EUR 327.6 |
Description: Affinity purified Rabbit polyclonal CD22 antibody |
CD22 antibody |
|||
70R-9913 | Fitzgerald | 50 ug | EUR 560.4 |
Description: Affinity purified rabbit polyclonal CD22 antibody |
CD22 antibody |
|||
70R-9914 | Fitzgerald | 50 ug | EUR 560.4 |
Description: Affinity purified rabbit polyclonal CD22 antibody |
CD22 Antibody |
|||
AF6970 | Affbiotech | 100ul | EUR 420 |
CD22 Antibody |
|||
CSB-PA828492-100ul | Cusabio | 100ul | EUR 379.2 |
Description: A polyclonal antibody against CD22. Recognizes CD22 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000 |
CD22 Antibody |
|||
1-CSB-PA576542 | Cusabio |
|
|
Description: A polyclonal antibody against CD22. Recognizes CD22 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200 |
CD22 Antibody |
|||
1-CSB-PA070294 | Cusabio |
|
|
Description: A polyclonal antibody against CD22. Recognizes CD22 from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/40000 |
CD22 Antibody |
|||
1-CSB-PA616669 | Cusabio |
|
|
Description: A polyclonal antibody against CD22. Recognizes CD22 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200 |
CD22 Antibody |
|||
DF7646 | Affbiotech | 200ul | EUR 420 |
CD22 Antibody |
|||
1-CSB-PA004900ESR1HU | Cusabio |
|
|
Description: A polyclonal antibody against CD22. Recognizes CD22 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
CD22 antibody |
|||
PAab10004 | Lifescience Market | 100 ug | EUR 463.2 |
CD22 Antibody |
|||
P1034-01m | SAB | 0.1m | EUR 242.4 |
CD22 Antibody |
|||
P1034-1ml | SAB | 1ml | EUR 1033.2 |
CD22 Antibody |
|||
R30191 | NSJ Bioreagents | 100 ug | EUR 419 |
CD22 Antibody |
|||
R32000 | NSJ Bioreagents | 100 ug | EUR 419 |
CD22 Antibody |
|||
CSB-PA828492- | Cusabio | each | EUR 402 |
Description: A polyclonal antibody against CD22. Recognizes CD22 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000 |
CD22 Antibody |
|||
V8228-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: Recognizes a protein of 130-140kDa, identified as CD22 (also known as BL-CAM). CD22 expression is restricted to normal and neoplastic B cells and is absent from other haemopoietic cell types. In B-cell ontogeny, CD22 is first expressed in the cytoplasm of pro-B and pre-B cells, and on the surface as B cells mature to become IgD+. It is not expressed by plasma cells, CD22 is found highly expressed in follicular mantle and marginal zone B-cells, and while germinal center B-cells are relatively weak. CD22 is a member of the immunoglobulin superfamily and serves as an adhesion receptor for sialic acid-bearing ligands expressed on erythrocytes and all leukocyte classes. It also associates with tyrosine kinases and play a role in signal transduction and B-cell activation. |
CD22 Antibody |
|||
V8228-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: Recognizes a protein of 130-140kDa, identified as CD22 (also known as BL-CAM). CD22 expression is restricted to normal and neoplastic B cells and is absent from other haemopoietic cell types. In B-cell ontogeny, CD22 is first expressed in the cytoplasm of pro-B and pre-B cells, and on the surface as B cells mature to become IgD+. It is not expressed by plasma cells, CD22 is found highly expressed in follicular mantle and marginal zone B-cells, and while germinal center B-cells are relatively weak. CD22 is a member of the immunoglobulin superfamily and serves as an adhesion receptor for sialic acid-bearing ligands expressed on erythrocytes and all leukocyte classes. It also associates with tyrosine kinases and play a role in signal transduction and B-cell activation. |
CD22 Antibody |
|||
V8228SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: Recognizes a protein of 130-140kDa, identified as CD22 (also known as BL-CAM). CD22 expression is restricted to normal and neoplastic B cells and is absent from other haemopoietic cell types. In B-cell ontogeny, CD22 is first expressed in the cytoplasm of pro-B and pre-B cells, and on the surface as B cells mature to become IgD+. It is not expressed by plasma cells, CD22 is found highly expressed in follicular mantle and marginal zone B-cells, and while germinal center B-cells are relatively weak. CD22 is a member of the immunoglobulin superfamily and serves as an adhesion receptor for sialic acid-bearing ligands expressed on erythrocytes and all leukocyte classes. It also associates with tyrosine kinases and play a role in signal transduction and B-cell activation. |
CD22 Antibody |
|||
V2984-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: CD22 mediates B-cell B-cell interactions. May be involved in the localization of B-cells in lymphoid tissues. Binds sialylated glycoproteins; one of which is CD45. Preferentially binds to alpha-2,6-linked sialic acid. The sialic acid recognition site can be masked by cis interactions with sialic acids on the same cell surface. Upon ligand induced tyrosine phosphorylation in the immune response seems to be involved in regulation of B-cell antigen receptor signaling. Plays a role in positive regulation through interaction with Src family tyrosine kinases and may also act as an inhibitory receptor by recruiting cytoplasmic phosphatases via their SH2 domains that block signal transduction through dephosphorylation of signaling molecules. [UniProt] |
CD22 Antibody |
|||
V2984-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: CD22 mediates B-cell B-cell interactions. May be involved in the localization of B-cells in lymphoid tissues. Binds sialylated glycoproteins; one of which is CD45. Preferentially binds to alpha-2,6-linked sialic acid. The sialic acid recognition site can be masked by cis interactions with sialic acids on the same cell surface. Upon ligand induced tyrosine phosphorylation in the immune response seems to be involved in regulation of B-cell antigen receptor signaling. Plays a role in positive regulation through interaction with Src family tyrosine kinases and may also act as an inhibitory receptor by recruiting cytoplasmic phosphatases via their SH2 domains that block signal transduction through dephosphorylation of signaling molecules. [UniProt] |
CD22 Antibody |
|||
V2984SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: CD22 mediates B-cell B-cell interactions. May be involved in the localization of B-cells in lymphoid tissues. Binds sialylated glycoproteins; one of which is CD45. Preferentially binds to alpha-2,6-linked sialic acid. The sialic acid recognition site can be masked by cis interactions with sialic acids on the same cell surface. Upon ligand induced tyrosine phosphorylation in the immune response seems to be involved in regulation of B-cell antigen receptor signaling. Plays a role in positive regulation through interaction with Src family tyrosine kinases and may also act as an inhibitory receptor by recruiting cytoplasmic phosphatases via their SH2 domains that block signal transduction through dephosphorylation of signaling molecules. [UniProt] |
CD22 Antibody |
|||
V2985-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: Recognizes a protein of 130-140 kDa, identified as CD22 (also known as BL-CAM). CD22 expression is restricted to normal and neoplastic B cells and is absent from other haemopoietic cell types. In B-cell ontogeny, CD22 is first expressed in the cytoplasm of pro-B and pre-B cells, and on the surface as B cells mature to become IgD+. It is not expressed by plasma cells, CD22 is found highly expressed in follicular mantle and marginal zone B-cells, and while germinal center B-cells are relatively weak. CD22 is a member of the immunoglobulin superfamily and serves as an adhesion receptor for sialic acid-bearing ligands expressed on erythrocytes and all leukocyte classes. It also associates with tyrosine kinases and play a role in signal transduction and B-cell activation. |
CD22 Antibody |
|||
V2985-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: Recognizes a protein of 130-140 kDa, identified as CD22 (also known as BL-CAM). CD22 expression is restricted to normal and neoplastic B cells and is absent from other haemopoietic cell types. In B-cell ontogeny, CD22 is first expressed in the cytoplasm of pro-B and pre-B cells, and on the surface as B cells mature to become IgD+. It is not expressed by plasma cells, CD22 is found highly expressed in follicular mantle and marginal zone B-cells, and while germinal center B-cells are relatively weak. CD22 is a member of the immunoglobulin superfamily and serves as an adhesion receptor for sialic acid-bearing ligands expressed on erythrocytes and all leukocyte classes. It also associates with tyrosine kinases and play a role in signal transduction and B-cell activation. |
CD22 Antibody |
|||
V2985SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: Recognizes a protein of 130-140 kDa, identified as CD22 (also known as BL-CAM). CD22 expression is restricted to normal and neoplastic B cells and is absent from other haemopoietic cell types. In B-cell ontogeny, CD22 is first expressed in the cytoplasm of pro-B and pre-B cells, and on the surface as B cells mature to become IgD+. It is not expressed by plasma cells, CD22 is found highly expressed in follicular mantle and marginal zone B-cells, and while germinal center B-cells are relatively weak. CD22 is a member of the immunoglobulin superfamily and serves as an adhesion receptor for sialic acid-bearing ligands expressed on erythrocytes and all leukocyte classes. It also associates with tyrosine kinases and play a role in signal transduction and B-cell activation. |
CD22 Antibody |
|||
V3693-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: Recognizes a protein of 130-140kDa, identified as CD22 (also known as BL-CAM). CD22 expression is restricted to normal and neoplastic B cells and is absent from other haemopoietic cell types. In B-cell ontogeny, CD22 is first expressed in the cytoplasm of pro-B and pre-B cells, and on the surface as B cells mature to become IgD+. It is not expressed by plasma cells, CD22 is found highly expressed in follicular mantle and marginal zone B-cells, and while germinal center B-cells are relatively weak. CD22 is a member of the immunoglobulin superfamily and serves as an adhesion receptor for sialic acid-bearing ligands expressed on erythrocytes and all leukocyte classes. It also associates with tyrosine kinases and play a role in signal transduction and B-cell activation. |
CD22 Antibody |
|||
V3693-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: Recognizes a protein of 130-140kDa, identified as CD22 (also known as BL-CAM). CD22 expression is restricted to normal and neoplastic B cells and is absent from other haemopoietic cell types. In B-cell ontogeny, CD22 is first expressed in the cytoplasm of pro-B and pre-B cells, and on the surface as B cells mature to become IgD+. It is not expressed by plasma cells, CD22 is found highly expressed in follicular mantle and marginal zone B-cells, and while germinal center B-cells are relatively weak. CD22 is a member of the immunoglobulin superfamily and serves as an adhesion receptor for sialic acid-bearing ligands expressed on erythrocytes and all leukocyte classes. It also associates with tyrosine kinases and play a role in signal transduction and B-cell activation. |
CD22 Antibody |
|||
V3693SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: Recognizes a protein of 130-140kDa, identified as CD22 (also known as BL-CAM). CD22 expression is restricted to normal and neoplastic B cells and is absent from other haemopoietic cell types. In B-cell ontogeny, CD22 is first expressed in the cytoplasm of pro-B and pre-B cells, and on the surface as B cells mature to become IgD+. It is not expressed by plasma cells, CD22 is found highly expressed in follicular mantle and marginal zone B-cells, and while germinal center B-cells are relatively weak. CD22 is a member of the immunoglobulin superfamily and serves as an adhesion receptor for sialic acid-bearing ligands expressed on erythrocytes and all leukocyte classes. It also associates with tyrosine kinases and play a role in signal transduction and B-cell activation. |
CD22 Antibody |
|||
V3784-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: Recognizes a protein of 130-140kDa, identified as CD22 (also known as BL-CAM). CD22 expression is restricted to normal and neoplastic B cells and is absent from other haemopoietic cell types. In B-cell ontogeny, CD22 is first expressed in the cytoplasm of pro-B and pre-B cells, and on the surface as B cells mature to become IgD+. It is not expressed by plasma cells, CD22 is found highly expressed in follicular mantle and marginal zone B-cells, and while germinal center B-cells are relatively weak. CD22 is a member of the immunoglobulin superfamily and serves as an adhesion receptor for sialic acid-bearing ligands expressed on erythrocytes and all leukocyte classes. It also associates with tyrosine kinases and play a role in signal transduction and B-cell activation. |
CD22 Antibody |
|||
V3784-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: Recognizes a protein of 130-140kDa, identified as CD22 (also known as BL-CAM). CD22 expression is restricted to normal and neoplastic B cells and is absent from other haemopoietic cell types. In B-cell ontogeny, CD22 is first expressed in the cytoplasm of pro-B and pre-B cells, and on the surface as B cells mature to become IgD+. It is not expressed by plasma cells, CD22 is found highly expressed in follicular mantle and marginal zone B-cells, and while germinal center B-cells are relatively weak. CD22 is a member of the immunoglobulin superfamily and serves as an adhesion receptor for sialic acid-bearing ligands expressed on erythrocytes and all leukocyte classes. It also associates with tyrosine kinases and play a role in signal transduction and B-cell activation. |
CD22 Antibody |
|||
V3784SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: Recognizes a protein of 130-140kDa, identified as CD22 (also known as BL-CAM). CD22 expression is restricted to normal and neoplastic B cells and is absent from other haemopoietic cell types. In B-cell ontogeny, CD22 is first expressed in the cytoplasm of pro-B and pre-B cells, and on the surface as B cells mature to become IgD+. It is not expressed by plasma cells, CD22 is found highly expressed in follicular mantle and marginal zone B-cells, and while germinal center B-cells are relatively weak. CD22 is a member of the immunoglobulin superfamily and serves as an adhesion receptor for sialic acid-bearing ligands expressed on erythrocytes and all leukocyte classes. It also associates with tyrosine kinases and play a role in signal transduction and B-cell activation. |
CD22 Antibody |
|||
V3786-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: Mediates B-cell B-cell interactions. May be involved in the localization of B-cells in lymphoid tissues. Binds sialylated glycoproteins; one of which is CD45. Preferentially binds to alpha-2,6-linked sialic acid. The sialic acid recognition site can be masked by cis interactions with sialic acids on the same cell surface. Upon ligand induced tyrosine phosphorylation in the immune response seems to be involved in regulation of B-cell antigen receptor signaling. Plays a role in positive regulation through interaction with Src family tyrosine kinases and may also act as an inhibitory receptor by recruiting cytoplasmic phosphatases via their SH2 domains that block signal transduction through dephosphorylation of signaling molecules. [Uniprot] |
CD22 Antibody |
|||
V3786-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: Mediates B-cell B-cell interactions. May be involved in the localization of B-cells in lymphoid tissues. Binds sialylated glycoproteins; one of which is CD45. Preferentially binds to alpha-2,6-linked sialic acid. The sialic acid recognition site can be masked by cis interactions with sialic acids on the same cell surface. Upon ligand induced tyrosine phosphorylation in the immune response seems to be involved in regulation of B-cell antigen receptor signaling. Plays a role in positive regulation through interaction with Src family tyrosine kinases and may also act as an inhibitory receptor by recruiting cytoplasmic phosphatases via their SH2 domains that block signal transduction through dephosphorylation of signaling molecules. [Uniprot] |